Posted in | News

Update on Construction Work on Two EPR Reactors in China

During her visit today to the Taishan nuclear site (in Guangdong province), Mrs Nicole Bricq, the French Minister for Foreign Trade, accompanied by Luc Oursel, Chairman of AREVA’s Executive Board, and Henri Proglio, Chairman and CEO of EDF, was able to see for herself the progress made in the construction work on the two EPR reactors in China, carried out by the owner and future operator of the site, the Taishan Nuclear Power Joint Venture Company (TNPJVC), a 30% stake in which belongs to EDF, and the rest to CGNPC.

The building site for the 1st reactor has entered a significant new stage with the completion of the work installing the reactor vessel and the installation of four steam generators and the pressurizer inside the reactor building. The two EPR reactors currently being built in Taishan are benefiting from the lessons learned at EPR reactor sites in Finland and France; the welding work on the primary circuit1 was completed 30% quicker than at the Olkiluoto 3 site. It is also thanks to the relationships forged since the start of the project with the Flamanville 3 site, and the way that French and Chinese skills have complemented each other, that the time between the first concrete being poured and the installation of the dome was cut to just 24 months. Before the installation phase, the lessons learned from experience also helped to reduce the time taken to build the four steam generators, in France by 40% compared to those having been built for other EPR reactors, making the French nuclear industry more competitive.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.